Ali Rizvi to Insulin Resistance
This is a "connection" page, showing publications Ali Rizvi has written about Insulin Resistance.
Connection Strength
0.735
-
Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes. Medicina (Kaunas). 2022 Jan 11; 58(1).
Score: 0.167
-
Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies. Int J Mol Sci. 2021 Sep 17; 22(18).
Score: 0.164
-
Future perspectives of the pharmacological management of diabetic dyslipidemia. Expert Rev Clin Pharmacol. 2019 Feb; 12(2):129-143.
Score: 0.136
-
Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents. Metab Syndr Relat Disord. 2014 Feb; 12(1):1-10.
Score: 0.095
-
Hypertension, obesity, and inflammation: the complex designs of a deadly trio. Metab Syndr Relat Disord. 2010 Aug; 8(4):287-94.
Score: 0.076
-
Recognition and implications of the metabolic syndrome. J S C Med Assoc. 2004 Apr; 100(4):107-12.
Score: 0.049
-
Incretins, Pregnancy, and Gestational Diabetes. Curr Pharm Biotechnol. 2016; 17(7):597-602.
Score: 0.028
-
The role of elevated growth hormone on the increased atherosclerosis in patients with acromegaly. Angiology. 2012 Oct; 63(7):492-4.
Score: 0.021